The QualityStocks Daily Monday, March 23rd, 2020

Today's Top 3 Investment Newsletters

NetworkNewsWire (NBDR) +125.00%

QualityStocks (PNAT) +100.00%

MarketBeat (RTTR) +61.51%

The QualityStocks Daily Stock List

Clinigence Holdings, Inc. (CLNH)

Stock News Now, Investing.com, OTC Markets, Investors Hangout, Stock Market Watch, Morningstar, Stockopedia, Market Screener, Simply Wall St, BioPortfolio, GuruFocus, InvestorsHub, Stockhouse and GlobeNewswire reported beforehand on Clinigence Holdings, Inc. (CLNH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Clinigence Holdings, Inc., together with its subsidiaries, operates as a healthcare information technology company in the United States. It operates a cloud-based platform that enables healthcare organizations to provide value-based care and population health management. The Company provides advanced analytics-driven solutions to payers and providers to optimize clinical and financial performance. On March 22, 2019, Clinigence, LLC and QualMetrix, Inc. merged to become Clinigence Health. Formed in 2018, Clinigence Holdings has its corporate office in Atlanta, Georgia.

Clinigence Health brings together cost and quality data in one unified platform. This is so its customers can make better data-driven decisions to realize higher quality of care at lower total cost. Clinigence Health aggregates and normalizes its client’s multi-source data into its unified cloud-based platform, transforming it into readily available, actionable intelligence that supports critical clinical and financial decisions.

Clinigence Health combines Clinigence’s wealth of clinical quality reporting and outcomes improvement tools with QualMetrix’s strong cost and utilization analytics. This is to provide its customers with a comprehensive view of healthcare cost and quality for population health and value-based care.

Clinigence provides turnkey SaaS (Software as a Service) solutions. These solutions enable connected intelligence across the care continuum through transforming huge amounts of data into actionable insights. The Company’s solutions help healthcare organizations improve the quality and cost-effectiveness of care, enhance population health management, and optimize provider networks. Clinigence Health enables payers, providers, third-party administrators, and other healthcare and life sciences organizations to improve clinical and financial performance, assess, predict and mitigate risk, and to improve the quality and cost of care.

Clinigence’s platform also aggregates, integrates, and analyzes clinical electronic health record (EHR) and claims data; clinical and quality reports, including HEDIS, STAR, GPRO and MIPS; gaps in care reporting; risk-stratification of patients; predictive analytics; reporting of utilization metrics comprising Admits/1000, Beddays/1000, and ER Visits/1000; and pharmacy utilization analysis. The platform also generates a dashboard for each physician that includes financial, quality, and utilization metrics. Moreover, Clinigence offers yearly wellness visit and chronic care management services; and wearable devices for remote patient monitoring.

Last month, Clinigence Holdings and Accountable Healthcare America, Inc. (AHA), a foremost medical management platform company and provider network, provided an update to their shareholders. As earlier announced on November 12, 2019, Clinigence and AHA signed a Letter of Intent (LOI) to combine the two companies. Both companies proceeded expeditiously to complete the process. This included Clinigence’s Board obtaining a fairness opinion and AHA obtaining audited financials for 2017 and 2018. The two companies also identified and started negotiations for different potentially significant roll-up acquisitions.

The two companies were on the threshold of recently executing a definitive merger agreement when they received a confidential Letter Of Intent (LOI) to acquire both companies and also the roll-up acquisitions from a Nasdaq-listed Company (PubCo). The Boards of Directors of both companies made a decision to execute the LOI with the PubCo and to proceed with the process of combining into the PubCo. The expectation is that this process will take 4-6 months to complete, but could take longer.

In the event that the transaction with the PubCo does not take place, Clinigence and AHA presently intend to subsequently complete their earlier announced merger, although there can be no assurance that the proposed transaction between Clinigence and AHA will take place at all. If the transaction with the PubCo does take place, management from Clinigence and AHA will be charged with leading the new company.

Clinigence Holdings, Inc. (CLNH), closed Monday's trading session at $1.40, off by 25.5319%, on 125 volume with 5 trades. The average volume for the last 3 months is 1,513 and the stock's 52-week low/high is $0.970000028/$4.40000009.

chart

InnerScope Hearing Technologies, Inc. (INND)

NetworkNewsWire, BioSpace, Spotlight Growth, Street Insider, Stock Day Media, Morningstar, Simply Wall St, Accesswire, Financial Buzz, Dividend Investor, OTC Markets, Stockopedia, GuruFocus, TradingView, TipRanks, InvestorsHub, PR Newswire, Seeking Alpha, Stockwatch, Stockhouse, Central Charts, YCharts and Insider Financial reported previously on InnerScope Hearing Technologies, Inc. (INND), and today we report on the Company, here at the QualityStocks Daily Newsletter.

InnerScope Hearing Technologies, Inc. is a consolidator of the hearing aid industry. Its direct-to-consumer model is transforming the industry with its Walmart.com, Sears.com, and Kmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired. The Company formerly went by the name Innerscope Advertising Agency, Inc. It changed its corporate name to InnerScope Hearing Technologies, Inc. in August of 2017. Incorporated in 2012, InnerScope Hearing Technologies is headquartered in Roseville, California.

In essence, InnerScope Hearing Technologies is a manufacturer and Direct-to-Consumer (DTC) distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products, (Hearing Products) Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil (Hearing Health Products) (collectively its Hearing Product Portfolio). Furthermore, the Company plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing aid clinics. Its mission is to serve approximately 1.2 billion people globally that are suffering with 25db or greater hearing loss across the entire hearing impaired vertical from research and development (R&D) and manufacturing through direct consumer sales and services.

Moreover, Innerscope has expertise and is a leader in the distribution of Direct-to-Consumer hearing products through big box retailers. The Company is a technology driven business with highly scalable B2B (Business to Business) and B2C (Business to Consumer) solutions. Innerscope offers a B2B SaaS based Patient Management System (PMS) software program. In addition to improving operations and communication with patients, the Company will also provide a Buying Group experience for the audiology practice. This enables owners to lessen product costs and boost their margins.

InnerScope Hearing Technologies has its HearingVite™. The Company’s HearingVite™ is a Doctor-Formulated dietary hearing supplement plus multi-vitamin for maintaining proper hearing health. HearingVite™ was expressly designed to provide "Nutrition for the Ears" to help people with hearing problems and to help avoid future hearing issues.

This month, InnerScope Hearing Technologies announced that its complete line of Doctor-Formulated "Nutrition for the Ears" Dietary Hearing and Tinnitus Supplements can be purchased on Amazon.com and Amazon Prime. The Company’s complete line of Doctor-Formulated Hearing & Tinnitus Supplements include HEARINGVITE™, HEARINGVITE™ + MEMORY BOOST, and EAR-RING RELIEF™.

HEARINGVITE™ is formulated as a complete daily multi-vitamin and mineral supplement to help almost 50 million people in the United States with hearing problems through maintaining the levels of vitamins, minerals and nutritional supplements that medical research indicates may slow the progression of age-related hearing loss. HEARINGVITE™ + MEMORY BOOST is specifically designed and formulated for people age 50 years and above to increase memory and cognitive function for normal age-related memory loss. EAR-RING RELIEF™ is designed specifically to lessen ringing, hissing and buzzing noises in the ears of the 60 million Americans who struggle with those constant or recurring noise in the ears that ranges from irritating to debilitating (Tinnitus Sufferers).

InnerScope Hearing Technologies, Inc. (INND), closed Monday's trading session at $0.000098, off by 51.00%, on 147 volume with 25 trades. The average volume for the last 3 months is 58,499,112 and the stock's 52-week low/high is $0.000097999/$0.104999996.

chart

Sandfire Resources America, Inc. (SRAFF)

Proactive Investors, Stock Pulse, Street Insider, Junior Mining Network, Stockopedia, YCharts, TradingView, Investors Hub, Mining Journal, Annual Reports, Stockhouse, Simply Wall St and Minestat reported beforehand on Sandfire Resources America, Inc. (SRAFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sandfire Resources America, Inc. acquires, explores for, and develops resource properties in the United States and Canada. The OTCQB-listed Company explores for copper, cobalt, zinc, lead, and silver deposits. Its flagship property is the Black Butte copper project. The Company formerly went by the name Tintina Resources, Inc. It changed its corporate name to Sandfire Resources America, Inc. in January of 2018. Established in 1998, Sandfire Resources America is based in White Sulphur Springs, Montana.

The Black Butte copper project comprises approximately 7,684 acres of fee-simple lands and 4,541 acres in 239 Federal unpatented lode-mining claims situated in central Montana. Located north of White Sulphur Springs, the project’s property includes the Johnny Lee Deposit, which contains a copper concentration 10 times higher than many existing mines. The Black Butte Copper Project will be an underground mine. The Johnny Lee deposit has a Measured and Indicated Mineral Resource of 10.9 million tonnes (Mt) at an average copper grade of 2.9% for 311 thousand tonnes (kt) of contained copper (Cu) at a 1.0 % Cu cut-off grade. In addition, the Johnny Lee deposit has an Inferred Mineral Resource of 2.7 Mt at an average copper grade of 3.0% for 80 kt of contained Cu at a 1.0 % Cu cut-off grade. Forty-eight diamond drill holes completed by Sandfire Resources America have been used to update the Mineral Resource estimate for the Johnny Lee deposit. Metallurgical testing of the deposit has been integrated with systematic mineralogy to develop a copper recovery model. The updated copper cut-off grade of 1.0 % Cu is based upon updated recovery studies and price assumptions. This month, Sandfire Resources America advised that it achieved two key permitting milestones for the Black Butte Copper underground mining project in Montana. On March 13, 2020, two Montana Government agencies each issued important components of the overall permitting process for the Black Butte Copper project that are key to Sandfire receiving a Record of Decision (RoD) for its Mine Operating Permit (MOP). First is the release of Final Environmental Impact Statement (EIS) by the Montana Department of Environmental Quality (MTDEQ). Second, the Department of Natural Resources & Conservation (MTDNRC) issued a Preliminary Determination (PD) in response to the water right owners’ application to modify their irrigation water rights to include leasing water for mitigation for the Black Butte Copper project. Sandfire’s Chief Executive Officer and VP of Project Development, Mr. Rob Scargill, said, “We are delighted to have achieved these key milestones, which represent the culmination of a robust and lengthy permitting process. Together with our team of Montana-based environmental consultants, we have demonstrated that a modern underground mine can be developed and operated while fully protecting the environment and water resources.”

Sandfire Resources America, Inc. (SRAFF), closed Monday's trading session at $0.16, off by 2.1407%, on 63,132 volume with 4 trades. The average volume for the last 3 months is 36,847 and the stock's 52-week low/high is $0.0592/$0.309300005.

chart

Smart Sand, Inc. (SND)

Zacks, Streetwise Reports, ChartMill, LetStock, last10k, iWatch Markets, OilandGas360, TradingView, MacroTrends, Business Insider, MarketBeat, Investor Place, GuruFocus, Nasdaq, Stockhouse, Stocktwits, Seeking Alpha, YCharts, Barchart, Market Chameleon, Wallet Investor, Stocknews, Market Screener, CSI Market, GlobeNewswire, Morningstar, Investing.com and Simply Wall St reported earlier on Smart Sand, Inc. (SND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Smart Sand, Inc. is a fully integrated frac sand supply and services company listed on the NasdaqGS. It is a low-cost producer of high quality Northern White raw frac sand. In addition, the Company is a provider of proppant logistics solutions through its in-basin transloading terminal and wellsite storage solutions. As of February 26, 2020, Smart Sand had roughly 316 million tons of proven recoverable sand reserves. Incorporated in 2011, the Company is based in The Woodlands, Texas.

Fundamentally, Smart Sand provides complete mine to wellsite solutions to its customers. Northern White raw frac sand is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Smart Sand also provides logistics solutions to its customers by way of its Van Hook transloading terminal in the Bakken. It also provides SmartSystems wellsite proppant storage capabilities.

The Company owns and operates a frac sand mine and related processing facility near Oakdale, Wisconsin. Here, it can process 5.5 million tons annually. Smart Sand’s main facility opened in June of 2012. It is located strategically on the Canadian Pacific rail line near Oakdale. The Company’s clean running, ultra-efficient wet and dry sand processing plants enable it to separate and process the highest-quality sand in the right blends for its customers 24/7/365. This is while minimizing Smart Sand’s environmental impact at the same time.

Last month, Smart Sand announced results for Q4 and full year ended December 31, 2019. Mr. Charles Young, Smart Sand’s Chief Executive Officer, stated “In spite of challenging market conditions, Smart Sand delivered another solid quarter to finish out an impressive year. During 2019, we demonstrated the value of our mine to wellsite solutions strategy by increasing activity through our Van Hook terminal and beginning the buildup of our SmartSystems™ equipment. As of today, we have nine SmartSystems fleets leased to customers…”

Revenues of $233.1 million for the full year 2019 were the highest in the history of Smart Sand, representing a 10 percent increase over full year 2018 revenues of $212.5 million. Net Income was $31.6 million, or $0.79 per basic share and $0.78 per diluted share for the full year 2019, versus Net Income of $18.7 million, or $0.46 per basic and diluted share, for the full year 2018. This represents an increase of 69 percent year over year.

Smart Sand, Inc. (SND), closed Monday's trading session at $0.7301, off by 23.0258%, on 1,289 volume with 766 trades. The average volume for the last 3 months is 287,377 and the stock's 52-week low/high is $0.550100028/$4.61999988.

chart

The Baraboo Bancorporation, Inc. (BAOB)

Whale Wisdom, Penny Stock Hub, Wallet Investor, Business Wire, dividata, Barchart, InvestorsHub, YCharts, Stockhouse, Stockopedia, Investors Hangout, GuruFocus, TradingView, Dividend Investor, Simply Wall St, Morningstar, Nasdaq and Seeking Alpha reported earlier on The Baraboo Bancorporation, Inc. (BAOB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Baraboo Bancorporation, Inc. operates as the holding company for The Baraboo National Bank. The Bank provides diverse personal and business banking products and services. Since 1857, Baraboo State Bank has served the people of Baraboo, Wisconsin and its surrounding communities. The Baraboo Bancorporation is headquartered in Baraboo. The Company’s shares trade on the OTC Markets.

The Bank is locally owned and operated. Baraboo State Bank has eight office locations; five in Baraboo, one in Reedsburg, one in Portage, and one in Lake Delton. The Bank offers checking, NOW, money market, club, individual retirement, savings, and health savings accounts; and certificates of deposit. Additionally, Baraboo State Bank provides consumer loans consisting of auto, home, construction, and other loans, and also home equity lines of credit; and business loans, including commercial real estate, equipment, Partnership Buy-in or Buy-out, business start-up and purchase, acquisition and development, agricultural, and government loans. It also provides operating lines of credit and letters of credit. Furthermore, the Bank offers online, mobile, and phone banking services, as well as bill payment and cash management services.

Pertaining to Business Services, the Bank has its Analyzed Business Checking. This is the account for larger businesses wanting to use their higher balances to offset their greater activity with a higher earnings credit. This also includes cash intensive accounts.

The Bank also has its Business Checking 200. The design of Business Checking 200 is for businesses with lower transaction volume and, usually, lower average balances. Other Business Services of the Bank include Business Cash Management and Remote Deposit services; Business Debit Card and Credit Cards; Business Ready Reserve, as well as Business Loans and Lines of Credit.

Baraboo State Bank offers the aforementioned Agricultural Loans. The Bank offers Agricultural Real Estate Loans to support growing farms and to support capital expenditures required to maintain a productive farm. In addition, it finances existing agricultural operations. This includes dairy operations, grain crops, and livestock. The Bank can also finance agriculture equipment purchases or equity. It can assist with WHEDA, FSA, FarmerMac, and USDA financing.

The Baraboo Bancorporation, Inc. (BAOB), closed Monday's trading session at $2.20, off by 13.7255%, on 1,100 volume with 5 trades. The average volume for the last 3 months is 4,165 and the stock's 52-week low/high is $2.20000004/$4.50.

chart

Tonix Pharmaceuticals Holding Corp. (TNXP)

Alpha Stock News, Stocktwits, Zacks, Stock of the Week, Investchronicle, BioPharmCatalyst, Proactive Investors, Investors Observer, Nasdaq, GlobeNewswire, Investing.com, Stockhouse, WallStreetAlerts, NewsHeater, DBT news, CSI Market, Ceo.ca, last10k, MacroTrends, InvestorsHub, Green Leaf Pot Stocks, YCharts, Morningstar and Seeking Alpha reported earlier on Tonix Pharmaceuticals Holding Corp. (TNXP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company listed on the NasdaqGM. A research and development (R&D) enterprise, the Company concentrates on discovering and developing small molecules and biologics to treat pain, addiction and psychiatric conditions. Its lead product candidate is TNX-102 SL. It is in Phase 3 development as a bedtime treatment for fibromyalgia and Posttraumatic Stress Disorder (PTSD). Established in 2007, Tonix Pharmaceuticals is headquartered in New York, New York.

Regarding Posttraumatic Stress Disorder (PTSD), the Company has two development programs centering on PTSD. TNX-601 CR (tianeptine oxalate controlled-release tablets) is in development as a daytime treatment for PTSD, and also for depression. The first efficacy study will be performed outside the United States. It is expected to be IND-ready this year. TNX-1600 (a triple reuptake inhibitor) is a third product candidate undergoing development for PTSD, also as a daytime treatment. TNX-1600 is in preclinical development.

Tonix Pharmaceuticals’ TNX-102 SL is a potential bedtime treatment for agitation in Alzheimer’s disease (AAD). The FDA (Food and Drug Administration) has designated it a Fast Track development program.

Furthermore, the Company has two pre-IND programs focused on biodefense technologies. TNX-801 is a potential smallpox preventing vaccine containing a live synthetic version of horsepox virus. TNX-801 has unique properties that Tonix Pharmaceuticals believes may lower toxicity and offer potential safety advantages over existing vaccinia-based vaccines.

TNX-701 is a biodefense technology relating to the development of protective agents against radiation exposure. The Company has commenced nonclinical R&D on TNX-701. Tonix plans to develop it under the Animal Efficacy Rule.

In February, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of a vaccine, TNX-1800 (live modified horsepox virus vaccine for percutaneous administration) to protect against the new coronavirus disease, COVID-19, founded on Tonix Pharmaceuticals’ proprietary horsepox vaccine platform. Tonix is developing TNX-801 (live horsepox virus vaccine for percutaneous administration) as a potential smallpox preventing vaccine for the U.S. strategic national stockpile and as a monkeypox preventing vaccine.

Tonix believes that its proprietary horsepox virus has the potential to serve as a vector for vaccines to protect against other infectious agents. This new research collaboration will develop and test a potential horsepox vaccine that expresses protein from the virus that causes COVID to protect against the disease.

Tonix Pharmaceuticals Holding Corp. (TNXP), closed Monday's trading session at $0.8529, off by 12.0722%, on 5,000 volume with 21,060 trades. The average volume for the last 3 months is 9,304,162 and the stock's 52-week low/high is $0.390199989/$31.3999996.

chart

Twin Vee PowerCats, Inc. (TVPC)

Zacks, Street Insider, Penny Stock Hub, YCharts, Dividend Investor, TMXmoney, OTC Markets, Central Charts, Capital Cube, Stockwatch, Nasdaq, TipRanks, Digital Journal, GlobeNewswire, PR Web, Morningstar, OTC.Watch, Dividend.com, TradingView, Market Screener, Barchart, GuruFocus, Seeking Alpha, Stockopedia and Wallet Investor reported previously on Twin Vee PowerCats, Inc. (TVPC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Twin Vee PowerCats, Inc. is one of the largest production-based dual hull boat companies in the United States. It designs, manufactures, and sells recreational and commercial twin-hull power boats under the Twin Vee brand name. Over the past 25 years, It has centered on perfecting the high-speed twin-displacement hull design, also known as a "catamaran powerboat." Twin Vee PowerCats is one of the most recognized brands in the power catamaran industry. The Company has received numerous tributes and awards for industry achievements.

The Company was formerly known as ValueRich, Inc. It changed its name to Twin Vee PowerCats, Inc. in April of 2016. Twin Vee PowerCats is based in Fort Pierce, Florida and the Company lists on the OTC Markets.

Twin Vee PowerCats manufactures American-made products with American marine craftsmen in an American factory. An experienced workforce in Fort Pierce hand-builds Twin Vee boats. Twin Vee PowerCats regularly makes substantial investments into new technology. This augments its traditional hand-built process.

A few years ago, Twin Vee PowerCats began redesigning new boat models to ensure that potential boat buyers give twin-hulled boats a chance. Among the re-imagined boats it has developed, Twin Vee launched the 24-foot center console power catamaran in 2019 to enthusiastic acclaim. Center Console Life showcases the boat in its review. Furthermore, Twin Vee PowerCats’ 240 CC was featured by Florida Sportsman Magazine in 2019, stating that the "model certainly hits the mark for style points along with fishability."

Last week, Twin Vee PowerCats announced that because of the unprecedented state of the world because of the COVID-19 (Coronavirus) pandemic, Twin Vee's Management Team is monitoring developments in Florida and the country as a whole.

Mr. Joseph Visconti, President of Twin Vee PowerCats, said, "We want to assure our customers that we are 100 percent on top of this unfortunate situation. We will continue to follow the Center for Disease Control and Prevention for updates and observe any and all prescribed measures for the safety of our employees and the community at large."

Twin Vee PowerCats, Inc. (TVPC), closed Monday's trading session at $0.075, off by 16.6667%, on 887,052 volume with 2 trades. The average volume for the last 3 months is 11,781 and the stock's 52-week low/high is $0.05/$0.219999998.

chart

Trucept, Inc. (TREP)

Street Insider, Pennystocks.news, OTC Dynamics, Financial Content, Contexxia, Stock News Now, Stockhouse, TipRanks, Stockopedia, Market Screener, Ask Finny, GuruFocus, StockPulse, Infront Analytics, Business Insider, InvestorsHub, Investing Online, PR Newswire, Biz Journals, and stock2own reported earlier on Trucept, Inc. (TREP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Trucept, Inc. is a top consulting and service provider to the Professional Employer Organization and Consumer Goods industries. Through its subsidiaries, the Company provides professional employer organization staffing and business processing services to small and medium-size businesses in the USA. The Company formerly went by the name Smart-Tek Solutions, Inc. It changed its corporate name to Trucept, Inc. in January of 2013. Formed in 1995, Trucept has its corporate headquarters in Escondido, California.

In essence, Trucept facilitates sales for PEOs (Professional Employer Organizations). Additionally, the Company provides a broad array of consultation services, so that an entity can concentrate on growing their PEO business. Professional Employer Organizations are firms that provide a service under which an employer can contract out employee management tasks. Trucept is the marketing and advising arm of a number of nationally known Professional Employer Organizations.

The Company’s services enable customers to outsource human resources tasks. This includes payroll processing, workers' compensation insurance, health insurance, employee benefits, 401k investment services, personal financial management, and income tax consultation chiefly related to staffing comprising staff leasing, temporary staffing, and co-employment. Furthermore, Trucept provides healthcare staffing services.

Trucept’s Consultation Services include Management; Human Resources; Accounting; Performance Management and Counseling; IT (Information Technology) Support; and Harassment and Discrimination Training. Consultation Services also include Finance; Client Retention; Sales Consulting; as well as Onboarding and Orientation practices.

Chief Executive Officer, Mr. Norman Tipton, leads Trucept. Since 2007, Mr. Tipton has been an advisor to several publicly traded companies’ Boards. This includes Allegiant Professional Business Services, Inc. and Dalrada Financial Corp. In 2013, he joined the Board of Directors of Trucept. Mr. Tipton has previously held management positions at SAIC, a Fortune 500 defense industry company, and was the Human Resources Manager at the San Diego Union-Tribune, where he managed labor negotiations and relations.

Trucept, Inc. (TREP), closed Monday's trading session at $0.03, up 80.7229%, on 4,493,078 volume with 12 trades. The average volume for the last 3 months is 86,455 and the stock's 52-week low/high is $0.009999999/$0.054000001.

chart

Petrogress, Inc. (PGAS)

NetworkNewsWire, Marketbeat, Last10k, MarketWatch, Whale Wisdom, OilandGas360, Trading View, Investors Hangout, Stockhouse, Stockwatch, StockInvest, Barchart, 4-Traders, YCharts, Wallet Investor, Simply Wall St, GuruFocus, Stockopedia, and Dividend Investor reported earlier on Petrogress, Inc. (PGAS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Petrogress, Inc., by way of its subsidiaries, operates as an integrated merchant of petroleum products. The Company is an independent Oil energy and Shipping company. It specializes in oil exploration, production, trade and sea transportation with global operations throughout Europe, Africa and the Middle East. The Company owns and operates a fleet of tankers from its base in the historic Port of Piraeus through a series of Marshall Islands subsidiaries. Petrogress is based in Delaware and New York and lists on the OTC Markets.

The Company operates mainly as a holding company for its wholly-owned subsidiaries. Petrogress concentrates on the supply and trade of light petroleum fuel oil, refined oil products and other petrochemical products to local refineries in West Africa and Mediterranean countries.

In addition, Petrogress operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana. The Company is actively looking for expansion opportunities. This includes in operating and developing natural gas production and transmission facilities along with LNG processing in the United States, refinery operations in north and West Africa, and the transport and sales of LNG in Europe.

For Upstream - oil resources and exploration, Petrogress has its Petrogres Oil & Gas Energy, Inc. subsidiary. For Midstream - product fleet carriers, the Company has its Petronav Carries, LLC subsidiary. Regarding Downstream – processing and refining, it has its J/V PGO & PGL – Ghana subsidiary. Furthermore, regarding Marketing – purchases and sales, Petrogress has its Petrogres Co. Limited subsidiary.

In December of 2018, Petrogress announced that its Petrogress Int’l, LLC (PIL) subsidiary entered into a Partnership Agreement with Deliman Oil Company Limited, a Ghanaian corporation. This Agreement is to jointly create and co-operate a Ghanaian corporation to be called PG&D Fueling. PG&D will operate and manage gas/refueling stations in Ghana, Burkina Faso and Niger and associated storage and distribution operations.

The expectation is that PG&D will initially operate and manage 65 gas stations now owned by Deliman in Ghana and Burkina Faso. The petrochemical products to be distributed via PG&D managed gas stations will be supplied by PIL affiliate company Petrogres Co. Limited, via its partnership with Platon Oil Refinery in Ghana.

Recently, Petrogress announced that its PIL subsidiary entered into an Exclusive Distribution Agreement with Dana Lubricants Factory LLC (Dana Lubes), a United Arab Emirates (UAE) based lubricant oil manufacturer. This agreement designates PIL as the exclusive agent for distribution of products manufactured and branded by Dana Lubes throughout western Africa.

Petrogress, Inc. (PGAS), closed Monday's trading session at $0.15, up 113.98%, on 8,100 volume with 4 trades. The average volume for the last 3 months is 8,767 and the stock's 52-week low/high is $0.05/$2.79999995.

chart

Barfresh Food Group, Inc. (BRFH)

Greenbackers, RedChip, Marketbeat, SmallCapVoice, Lions of Wall Street, OTC Journal, Barchart, The Wall Street Transcript, SmallCap Network, and Wall Street Resources reported earlier on Barfresh Food Group, Inc. (BRFH), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Barfresh Food Group, Inc. is a manufacturer and distributor of unique, frozen, ready-to-blend beverages. These include smoothies, shakes, and frappes. These products are primarily for restaurant chains and the foodservice industry. Barfresh Food Group and Barfresh Food Group Pty Ltd. in Australia (Barfresh Australia) are under common control. Barfresh Food Group is headquartered in Beverly Hills, California.

Barfresh acquired the exclusive worldwide patent rights to its ready-to-blend beverage packs. This is on top of its presently held patent rights in the United States and Canada. The Company acquired the intellectual property (IP) for its creative “ready to blend” ingredient packs for North America.

Barfresh Food Group has approval to sell its products into all branches of the U.S. Armed Forces. This covers bases around the world that are home to 1.3 million active troops. Barfresh has entered into agreements expanding to a host of military locations.

Barfresh’s proprietary, patented system uses portion-controlled pre-packaged beverage ingredients. These deliver freshly made smoothies that are quick, cost efficient, and without waste.

The innovative system combines all the ingredients of a quality smoothie into an individually pre-portioned pack. The pack contains real fruit pieces, low fat frozen yogurt or sorbet, fruit juice, and ice. These are subsequently blended with water to create a smoothie.

In late January 2019, Barfresh Food Group announced that it has approvals for 100 locations across numerous branches of the military throughout the U.S. It expects all locations to be installed and pouring within the next 60 days (as of the end of January).

Mr. Riccardo Delle Coste, Barfresh Food Group's Chief Executive Officer, stated, "We now have over 100 locations compared to no military locations this time last year. Growth in the military channel is only one of the reasons we expect to achieve very strong top line growth in 2019. We continue to see strong progress in the education channel, and we also will be rolling out multiple products in a leading national restaurant chain with over 2,500 locations in 2019.”

Recently, Barfresh Food Group announced that it raised more than $4.3 million of capital via a private placement of equity and cash exercise of existing warrants. The Company completed this capital raise to accelerate growth.

Barfresh Food Group, Inc. (BRFH), closed Monday's trading session at $0.375, up 54.6392%, on 7,600 volume with 122 trades. The average volume for the last 3 months is 56,747 and the stock's 52-week low/high is $0.210099995/$0.75.

chart

Pura Naturals, Inc. (PNAT)

Stockwatch, Clay Trader, Insider Financial, Marketwired, OTC Markets, WhaleWisdon, YCharts, Spotlight Growth, Tip Ranks, Dividend Investor, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean by way of its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is based in Lake Forest, California.

The Company focuses on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Pura Marine division centers on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Additionally, Pura Naturals has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner.

Pura also has its new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.

In December, Pura Naturals announced that the Grease Beast products went live on HomeDepot.com. Mr. Robert Doherty, Chief Executive officer of Pura Naturals, stated on December 12, 2018, "We have been live on HomeDepot.com for only a few days, and orders are flowing. This is a solid moment for Pura Naturals. Given the talent we have brought into the Company and the breadth of the achievements thus far, we expect a very strong 2019 for the Grease Beast product line."

Pura Naturals, Inc. (PNAT), closed Monday's trading session at $0.003, up 100.00%, on 88,954 volume with 60 trades. The average volume for the last 3 months is 714,563 and the stock's 52-week low/high is $0.000799999/$0.189999997.

chart

Bemax, Inc. (BMXC)

Penny Investor Network, StockRockandRoll, PennyStockLocks, Penny Stock Tweets, Stock Guru, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2012, Bemax, Inc. is a growing global distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Listed on the OTCQB, Bemax is based in Dallas, Georgia.

The Company’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.

Bemax is pursuing opportunities in the fast-growing international Consumer Staples and Household Products Industries. The Company focuses on business development and mentoring. It synergizes these models into the household products industry.

Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a foremost U.S. manufacturer of value-priced, eco-friendly disposable baby diapers.

Bemax announced this past April that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. The Company officially filed for trademark on April 28, 2018 (Serial Number 87899104).

Bemax previously announced that its private label brands of sanitary pads and baby wipes would be available for sales commencing this month. The new Bemax private label brands are available on Walmart.com and on bemaxinc.com/webstore.

Shipment of the Company’s new private label brands to wholesalers and distributors started last month. Furthermore, Bemax will extend sales of its private label to other online selling platforms including target.com to support and grow online sales.

Bemax, Inc. (BMXC), closed Monday's trading session at $0.00015, up 50.00%, on 2,100 volume with 23 trades. The average volume for the last 3 months is 6,027,986 and the stock's 52-week low/high is $0.000029999/$0.000399999.

chart

Adama Technologies Corporation (ADAC)

StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.

Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.

Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.

This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.

Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts. It continues to work as a US government contractor.

Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.

SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States. In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.

The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.

Recently, Adama Technologies announced that it was accepted and successfully up-listed to the OTCQB marketplace with OTC Markets. Adama had outlined a course towards growth and development. This path included development of additional revenue streams, growing revenues within their present operations, and up-listing into the QB Marketplace.

Adama Technologies also announced that the Company will bid on an additional $3,000,000 in new government contracts with at least $2,000,000 of that number being for US Military Defense contracts. Adama detailed its month-of-March bidding plan and strategy and its optimism concerning its ability to win these contracts. As the bidding process is underway, Adama Technologies will continue to look for additional revenue opportunities in its commercial and retail outlets.

Adama Technologies Corporation (ADAC), closed Monday's trading session at $0.0002, up 100.00%, on 10,600 volume with 1 trade. The average volume for the last 3 months is 83,735 and the stock's 52-week low/high is $0.000099999/$0.0037.

chart

KinerjaPay Corp. (KPAY)

OTC Markets, InvestorsHub, MarketWatch, TradingView, Stockhouse, Marketbeat, and Barchart  reported on KinerjaPay Corp. (KPAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Established in 2010, KinerjaPay Corp. focuses on operating  a  digital payment and  e-commerce platform.  The  Company,  through  its wholly-owned subsidiary,  PT Kinerja Pay Indonesia, enables consumers to "pay, play,  and buy"  via  its secure website and mobile applications.  KinerjaPay’s intention is to establish the Company as a leader in Indonesia's digital economy, with a specific emphasis on the middle- and low-income markets.  KinerjaPay  is based in Indonesia.

A digital payment and ecommerce platform,  KinjerPay’s  services are available through its mobile applications,  and  on its website at www.kinerjapay.com.  The  KinerjaPay platform provides a secure payment solution.  In addition, it  provides  a developing  virtual marketplace  where participants can buy and sell products and services.

In May 2016, KinerjaPay entered into a partnership with Bitcoin Indonesia. This makes KinerjaPay the first e-commerce portal in Indonesia authorized to accept and transact Bitcoin  across its platform. This  enables  account holders to convert the virtual currency to Indonesian Rupiah to pay their bills, transfer money, or make purchases in the Company's ecommerce market.

KinerjaPay  offers several  in-app services that cater  to mobile users. These in-app services include  an eWallet, social engagement, and digital entertainment related applications. Additionally,  the Company is  pursuing other e-commerce verticals. These include travel, fashion, gaming, and  productivity applications.

Moreover, KinerjaPay  has  created  a number of unique  features designed to engage users. This includes  an  interactive gamification component that  permits  users to play and earn rewards while enjoying the benefits of shopping online. The Company is also  providing users the convenience of making online payments of their utility bills, phone top-ups/data plans, insurance premiums, automobile loan instalments, and many  other  applications.

KinerjaPay plans to expand its digital ecommerce platform with the launch of KinerjaGames. It entered a long-term License Agreement with Ace Legends Pte. Ltd. (ACE). ACE is a  Singapore-based game developer.

With this Agreement, in exchange for a $100,000 investment, KinerjaPay will become the exclusive, worldwide Game Publisher License for ACE games. The Company will also host all the games now published by ACE on its own KinerjaGames platform.

This past October, KinerjaPay announced its partnership with Uber Technologies, Inc. Uber is the worldwide smartphone-enabled 'Ride-Hailing' service.

With this partnership, Uber will grant KinerjaPay users an exclusive promotion code for first-time users, valid for four rides. Users can at first redeem the Uber/KinerjaPay promotion code by creating a new account on the Company's eCommerce platform or meeting a certain spending threshold with KinerjaPay's proprietary KinerjaMall service. User/clients can subsequently redeem their unique code directly in their KinerjaPay smartphone app to use the Uber service.

Recently, KinerjaPay announced that it has chosen Blockchain Industries, Inc. and Fintech Global Consultants to transition to a token payment platform. Blockchain Industries, in partnership with Fintech Global Consultants, will be guiding KinerjaPay in its transition from an electronic payment platform to a token payment platform.

KinerjaPay’s plan is to raise up to US $5 million from its imminent ICO (initial coin offerings). The ICO will be offered to institutional or private investors in the form of KCOIN, KinerjaPay's own proprietary virtual currency. With the ICO, KCOIN will be used as KinerjaPay's cryptocurrency on one of the largest cryptocurrency exchanges in Asia.

KinerjaPay Corp. (KPAY), closed Monday's trading session at $0.0035, up 45.8333%, on 203,156 volume with 336 trades. The average volume for the last 3 months is 7,790,885 and the stock's 52-week low/high is $0.0017/$0.859000027.

chart

The QualityStocks Company Corner

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

Despite the challenges of the COVID-19 pandemic, PowerBand Solutions Inc. (TSXV:PBX)(OTCQB:PWWBF)(Frankfurt:1ZVA) remains on track to secure extensive credit facilities that will be made available on its cloud-based transaction platform, to enable consumers to buy, lease and sell vehicles on their smart phones or home computers.

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Monday's trading session at $0.064446, up 9.9761%, on 355,201 volume with 6 trades. The average volume for the last 3 months is 41,734 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been awarded two U.S. patents for its industry-leading technology, PrintRite3D(R). According to the update, the patents include: U.S. Application No.: 16/234,333 Titled: Systems and Methods for Additive Manufacturing Operations; and U.S. Application No.: 16/282,004 Titled: Systems and Methods for Measuring Radiated Thermal Energy During an Additive Manufacturing Operation. To view the full press release, visit http://nnw.fm/c8L0R

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Monday's trading session at $2.26, off by 9.60%, on 44,769 volume with 342 trades. The average volume for the last 3 months is 72,477 and the stock's 52-week low/high is $2.18109989/$18.50.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced its March 19, 2020, closing on its previously announced private offering of common stock and warrants resulting in gross proceeds of $3,498,612 to the Company. To view the full press release, visit http://nnw.fm/7W7Hy

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $1.37, off by 0.724638%, on 5,326,374 volume with 456 trades. The average volume for the last 3 months is 468,285 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. To view the full press release, visit http://nnw.fm/ZxG4j

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $2.27, off by 9.5618%, on 453,714 volume with 4,066 trades. The average volume for the last 3 months is 8,104,947 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019. To view the full press release, visit http://nnw.fm/8BFk6

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Monday's trading session at $0.8137, up 0.357671%, on 13,247,685 volume with 1,677 trades. The average volume for the last 3 months is 126,077 and the stock's 52-week low/high is $0.630800008/$6.25.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://cnw.fm/4NW8h

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.31819, off by 0.565625%, on 53,408 volume with 103 trades. The average volume for the last 3 months is 115,645 and the stock's 52-week low/high is $0.229499995/$1.34000003.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) was featured today in the 420 with CNW by CannabisNewsWire. Compared to other states, cannabis legalization efforts in New York have been slow. Both hemp and marijuana bills have been held up in various stages of the legalization process, and the emergence of the coronavirus has thrown a wrench into the works. For instance, Governor Cuomo had been planning on carrying out benchmarking visits to legal cannabis states, but he has stated that the tour has been delayed as the country deals with the coronavirus pandemic.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Monday's trading session at $0.25, off by 21.875%, on 81,304 volume with 21 trades. The average volume for the last 3 months is 8,208 and the stock's 52-week low/high is $0.239999994/$2.1775.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders (OTC: NBDR) on Friday announced that its subsidiary, MediDent Supplies, has begun expedited air freight shipments of medical equipment and supplies into its operations center in Phoenix, Arizona. To view the full press release, visit http://cnw.fm/Hzqe9

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Monday's trading session at $0.045, up 125.00%, on 147,292 volume with 2,237 trades. The average volume for the last 3 months is 1,049,041 and the stock's 52-week low/high is $0.008299999/$0.0581.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has commenced delivery on its large government tender for up to 15,000 push-to-talk devices, previously announced on December 02, 2019. To view the full press release, visit http://nnw.fm/BVm3p

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.1069, up 4.8039%, on 60,800 volume with 11 trades. The average volume for the last 3 months is 150,707 and the stock's 52-week low/high is $0.095499999/$0.429100006.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced that its subsidiary, hempSMART(TM), will offer products to consumers at a substantial savings. To view the full press release, visit http://cnw.fm/F3Oap

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.015548, up 3.6533%, on 27,262 volume with 184 trades. The average volume for the last 3 months is 1,420,155 and the stock's 52-week low/high is $0.012099999/$1.08000004.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is an innovator in the cannabis sector whose mission is to cultivate the world’s best cannabis and earn recognition as a leader in the global industry. By holding a global and diversified portfolio, the company has emerged as one of the world’s fastest-growing, premium plant-driven lifestyle companies. The Toronto Stock Exchange symbol ‘FIRE’ is a testament to the passion for quality cannabis that drives the production of the company’s premium products. Also today, the company was highlighted today in a publication from Stock Markets Press, examining how reports have shown that CBD for pets is a market on its own, but it may also trigger additional sales or come from those add-on sales. As consumers take CBD products, they may try addition ones for pets. Or they may buy CBD for pets first, then try CBD products for humans themselves. Either way, the pet CBD market cannot be seen only by itself. It is probably tied to CBD sales to human owners, as well.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.149316, off by 1.9026%, on 521,676 volume with 290 trades. The average volume for the last 3 months is 532,849 and the stock's 52-week low/high is $0.101000003/$1.75.

Recent News

chart

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Monday's trading session at $0.28, off by 3.45%, on 681,238 volume with 95 trades. The stock's 52-week low/high is $0.27/$0.295.

Recent News

chart

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship insurtech software platform, InsuraGuest, to provide hotels, resorts and vacation rental properties with a specialized Hospitality Liability insurance policy. The platform and policy combination help transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability policy to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which automatically extends the policy to each registered guest and its occupants at check-in, for an additional nightly fee. The specialized Hospitality Liability policy affords coverage for accidental in-room property damage, theft of personal property, as well as accidental medical, and accidental death and dismemberment.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Monday's trading session at $0.14, up 12.00%, on 6,000 volume with 1 trade. The average volume for the last 3 months is 47,768 and the stock's 52-week low/high is $0.045/$0.34.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $0.346, up 5.2135%, on 99,686 volume with 64 trades. The average volume for the last 3 months is 49,030 and the stock's 52-week low/high is $0.279000014/$4.49989986.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.